Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Video

Track: Non-CME Session

SESSION 8: Professional Development (not for CME credit)

Friday, November 10, 2023
5:00 PM – 5:50 PM CST

    Moderator(s)

  • Daniel George, MD

    Duke University Medical Center
    Duke University School of Medicine
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • Bradley Leibovich, MD

    Mayo Clinic
    Mayo Clinic, Minnesota, United States

    Disclosure(s): Ownership Interest: I own stocks of the Commercial entity: Pathright Medical (Ongoing)

  • Jose Perez, MD

    Exelixis
    San Francisco, California, United States

    Disclosure(s): Ownership Interest: I own stocks of the Commercial entity: Exelixis, INC (Ongoing)
    Salary or Employment Relationship (does not included small non-employed consulting arrangements): Exelixis, INC (Ongoing)

  • Phillip Pierorazio, MD

    Penn Medicine
    Penn Presbyterian Medical Center, Penn Medicine
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Non-CE Consulting: Amgen, Merck, Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, SeaGen, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peloton Therapeutics, and Pfizer (Terminated)

  • W. Kimryn Rathmell, MD, PhD

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center
    Nashville, TN, United States

    Disclosure(s): Ownership Interest: I have received future stock options from the Commercial entity: Sitryx (Ongoing)
    Ownership Interest: I own stocks of the Commercial entity: Caribou (Ongoing)

  • Brian Rini, MD

    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee, United States

    Disclosure(s): No financial relationships to disclose

  • TZ

    Tian Zhang, MD, MHS

    The University of Texas Southwestern Medical Center
    UT Southwestern
    Dallas, TX, United States

    Disclosure information not submitted.

    • Speaker(s)

  • Phillip Pierorazio, MD

    Penn Medicine
    Penn Presbyterian Medical Center, Penn Medicine
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Non-CE Consulting: Amgen, Merck, Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, SeaGen, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peloton Therapeutics, and Pfizer (Terminated)

Presentations:

  • 5:01 PM – 5:15 PM CST
    Institutional Wellness

    Speaker: Phillip M. Pierorazio, MD – Penn Medicine

  • 5:15 PM – 5:20 PM CST
    SESSION 8: Q&A

    Speaker: Phillip M. Pierorazio, MD – Penn Medicine

  • 5:20 PM – 5:50 PM CST
    Workshop: Complications and Death: Impact on Cancer Providers

    Moderator: Phillip M. Pierorazio, MD – Penn Medicine

  • 5:20 PM – 5:50 PM CST
    Workshop: Industry Discussion About Career Paths in Industry

    Moderator: Jose R. Perez, MD – Exelixis

  • 5:20 PM – 5:50 PM CST
    Workshop: Mid-Career Itch, When is it Time to Transition Job? New Role? New Location?

    Moderator: W. Kimryn Rathmell, MD, PhD – Vanderbilt University Medical Center

    Moderator: Bradley C. Leibovich, MD – Mayo Clinic

    Moderator: Daniel J. George, MD – Duke University Medical Center

  • 5:20 PM – 5:50 PM CST
    Workshop: Starting a Career, Early Career

    Moderator: Brian Rini, MD – Vanderbilt-Ingram Cancer Center

    Moderator: Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center